Christopher Thunander - 15 Aug 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Reporting relationship: Chief Accounting Officer
Issuer ticker: N/A
Reported as of: 15 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2022, 13:45:31 UTC
Prior SEC filing: 16 Feb 2022
Next SEC filing: 09 Aug 2023
Source filing: View source filing
Reporting owner signature: By Jessica Rumschlag as attorney in fact

Key filing fact

Christopher Thunander filed Form 4 for SURGALIGN HOLDINGS, INC. on 17 Aug 2022.

Key facts

This page summarizes Christopher Thunander's Form 4 filing for SURGALIGN HOLDINGS, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 13:45.

Change

Previous filing in this sequence was filed on 16 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Award

Transaction value: $0
Shares: +15,666
Change %: +123%
Price: $0.000000
Shares after: 28,360
Date: 15 Aug 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Restricted Stock Units will vest over two years with one-half of the total number of shares vesting on the first anniversary of the award date and the remaining shares vesting prorated quarterly.

Footnote F2

The total shares reported reflect 1:30 reverse stock split on May 17, 2022 and include 1,056 shares purchased under the Company's Employee Stock Purchase Plan on June 30, 2022, which is exempt under Rule 16b-3(c).